Hui-Chun Lai

Title: Hui-Chun Lai: Innovator in Bioceramics

Introduction

Hui-Chun Lai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of bioceramics, particularly in the development of materials for medical applications. With a total of 2 patents, his work focuses on innovative solutions for hard tissue implants.

Latest Patents

Hui-Chun Lai's latest patents include advancements in dicalcium phosphate ceramics and surgical cement. The first patent discloses a method for manufacturing pure dicalcium phosphate ceramics or dicalcium phosphate/hydroxyapatite biphasic ceramics. These materials are designed for use as implant materials in hard tissue areas. The manufacturing process involves using an acidic phosphate compound, a basic calcium phosphate compound, and water. The resulting ceramics can be in granular or block form, providing versatility for medical applications.

The second patent focuses on a surgical cement that is bioresorbable and bioactive. This cement is composed of a basic calcium phosphate and an acidic calcium citrate, with a specific weight ratio that ensures optimal performance. The surgical cement is particularly useful in orthopedic, maxillofacial, and dental applications due to its favorable flow characteristics and relatively short setting time.

Career Highlights

Hui-Chun Lai is associated with Maxigen Biotech Inc., where he continues to innovate in the field of bioceramics. His work has garnered attention for its potential to improve medical outcomes through advanced materials.

Collaborations

Hui-Chun Lai has collaborated with notable colleagues, including Sung-Tsuen Liu and Sung-Ching Chen. These partnerships have contributed to the development of his innovative patents and advancements in bioceramics.

Conclusion

Hui-Chun Lai is a key figure in the field of bioceramics, with a focus on developing materials for medical applications. His patents reflect a commitment to innovation and improving healthcare solutions.